DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main
Source: SEC Form 13F · as of Mar 2026DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main holds 21 biotech & pharma companies tracked by BioSniper, totaling $466.6M in value as of Mar 2026 (SEC Form 13F).
Companies held
21
Total value held
$466.6M
BioSniper AIPage evidence connected
Prepared research question
What matters most for GILEAD SCIENCES, INC. (GILD)—catalysts, financial risk and supporting evidence?
Run cited research
Traceable citations · Unknowns marked
| Company | Shares | Value |
|---|---|---|
| GILDGILEAD SCIENCES, INC. | 2,122,979 | $295.9M |
| REGNREGENERON PHARMACEUTICALS, INC. | 38,270 | $29.6M |
| INVAInnoviva, Inc. | 892,336 | $20.8M |
| INCYIncyte Corp. | 183,834 | $17.3M |
| TEVATeva Pharmaceutical Industries Limited | 502,931 | $15.1M |
| PTCTPTC THERAPEUTICS, INC. | 213,363 | $14.5M |
| EXELEXELIXIS, INC. | 334,487 | $14.3M |
| IONSIONIS PHARMACEUTICALS INC | 167,657 | $12.6M |
| BBIOBridgeBio Pharma, Inc. | 139,510 | $10.4M |
| INSMINSMED Inc | 60,175 | $9.8M |
| BMRNBIOMARIN PHARMACEUTICAL INC | 109,031 | $6.2M |
| RDYDR REDDYS LABORATORIES LTD | 400,000 | $5.5M |
| ONCBeOne Medicines Ltd. | 10,692 | $3.2M |
| SUPNSUPERNUS PHARMACEUTICALS, INC. | 52,809 | $2.7M |
| ARGXARGENX SE | 3,597 | $2.6M |
| ROIVRoivant Sciences Ltd. | 76,955 | $2.1M |
| NAMSNEWAMSTERDAM PHARMA CO N.V. | 46,936 | $1.5M |
| ALNYALNYLAM PHARMACEUTICALS, INC. | 3,500 | $1.2M |
| MRNAModerna, Inc. | 15,361 | $779K |
| CHRSCoherus Oncology, Inc. | 159,990 | $270K |
| ALECAlector, Inc. | 69,666 | $150K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.